Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells
US6312692A · kind A · utility
22Cited by
3References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 30, 1998 |
| Grant date | Nov 6, 2001 |
| Priority date | — |
| Expiry date | Apr 30, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating graft-vs-host diseases by administration of bone marrow and an anti-gp39 antibody specific to human gp39 is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.